基于鄞州区域医疗数据的利巴韦林临床使用的分析

Analysis of Ribavirin Utilization Based on Yinzhou Healthcare Database

目的描述宁波市鄞州区医疗机构门诊利巴韦林的使用情况。方法利用鄞州区医疗卫生信息数据库对3家综合性医院,24家社区卫生服务中心在2010年至2016年期间利巴韦林门诊使用情况进行分析。结果研究期间,鄞州区医疗机构门诊中利巴韦林处方量为1587 504次,使用人数为673 661,其中利巴韦林注射液和粉针处方数占97.74%。利巴韦林处方主要由一级医疗机构开出,处方次数和人数呈逐年减少趋势。14岁及以下儿童处方人次数约占总处方数的50.56%。患者用药原因主要为急性上呼吸道感染,约占总处方数的68.85%。结论利巴韦林处方仍存在不合理,尤其对于注射剂临床上使用应该进一步规范处方适应证,密切关注治疗情况。

Objective To describe the clinical utilization of ribavirin in Ningbo city,Yinzhou District.Methods We conducted a descriptive analysis of the clinical utilization of ribavirin in3general hospitals and24community health centers from2010to2016by using Yinzhou healthcare information database.Results During the study period,we found1587504outpatients'prescriptions of ribavirin and673,661ribavirin users.Ribavirin injections accounted for97.74%of all ribavirin prescriptions.In addition,ribavirin was mainly prescribed by primary grade medical institutions.The result showed the number of prescriptions and users of ribavirin was decreasing.Moreover,ribavirin prescriptions of children(≤14)accounted for50.56%of the total number of ribavirin prescriptions.Among all ribavirin prescriptions,there were68.85%recorded diagnosis of acute upper respiratory tract infection.Conclusion The results indicated that there were large amount of irrational prescriptions of ribavirin.Clinicians should adhere to the indication of ribavirin injection and pay attention to the treatment.